Femasys Inc (FEMY) income statement
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $9.63MP/E –Yield –
Femasys Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 60.9%
- Operating margin
- -763.9%
- Net margin
- -511.8%
- Return on equity, FY2025
- -455.8%
Financial strength
- Current ratio
- 2.14
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 37.1%
Valuation
- P/E ratio
- –
- Price to sales
- 4.19
- Price to book
- 2.39
- Dividend yield
- –
See a number that looks wrong?